Pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering from sepsis, researchers have discovered. This discovery may lead to a therapy for sepsis, a major cause of death in developed countries that is fatal in one in four cases.